Regression and spreading of self-recognition during the development of autoimmune demyelinating disease

Journal of Autoimmunity

Volumn 13, Issue 1, 1999, Pages 11-20

  Tuohy, Vincent K ^a   Yu, Min ^a   Yin, Ling ^a   Kawczak, Julie A ^a   Kinkel, Philip R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Epitope spreading encephalomyelitis; Multiple sclerosis; Myelin proteolipid protein; T cell

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; AUTOIMMUNE DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; EPITOPE MAPPING; FEMALE; HELPER CELL; HISTOLOGY; IMMUNOCYTOCHEMISTRY; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE;

EID: 0032765901     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0293     Document Type: Conference Paper

References (44)

1. Martin R., McFarland H.F., McFarlin D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:1992;153-187.
2. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:1996;299-302.
3. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:1992;155-157.
4. McRae B.L., Vanderlugt C.L., Dal Canto M.C., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:1995;75-85.
5. Yu M., Johnson J.M., Tuohy V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: A basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1996;1777-1788.
6. Vanderlugt C.L., Miller S.D. Epitope spreading. Cur. Opinion Immunol. 8:1996;831-836.
7. Tuohy V.K., Yu M., Weinstock-Guttman B., Kinkel R.P. Diversity and plasticity of self-recognition during the development of multiple sclerosis. J. Clin. Invest. 99:1997;1682-1690.
8. Yu M., Kinkel R.P., Weinstock-Guttman B., Cook D.J., Tuohy V.K. HLA-DP: a class II restriction molecule involved in epitope sprcading during the development of multiple sclerosis. Human Immunol. 59:1998;15-24.
9. Tuohy V.K., Yu M., Yin L., Kawczak J.A., Johnson J.M., Mathisen P.M., Weinstock-Guttman B., Kinkel R.P. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 164:1998;93-100.
10. Tuohy V.K., Yu M., Yin L., Kawczak J.A., Kinkel R.P. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J. Exp. Med. 189:1999;1033-1042.
11. Beck R.W., Cleary P.A., Trobe J.D., Kaufman D.I., Kupersmith M.J., Paty D.W., Brown C.H. The effect of corticosteroid for acute optic neuritis on the subsequent development of multiple sclerosis. N. Eng. J. Med. 329:1993;1764-1769.
12. Morrissey S.P., Miller D.H., Kendall B.E., Kingsley D.P., Kelly M.A., Francis D.A., MacManus D.G., McDonald W.I. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain. 116:1993;135-146.
13. Filippi M., Horsfield M.A., Morrissey S.P., MacManus D.G., Rudge P., McDonald W.I., Miller D.H. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology. 44:1994;635-641.
14. Milner R.J., Lai C., Nave K.-A., Lenoir D., Ogata J., Sutcliffe J.G. Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell. 42:1985;931-939.
15. Macklin W.B., Campagnoni C.W., Deininger P.L., Gardinier M.V. Structure and expression of the mouse myelin proteolipid protein gene. J. Neurosci. Res. 18:1987;383-394.
16. Geysen H.M., Rodda S.J., Mason T.J., Tribbick G., Schoofs P.G. Strategies for epitope analysis using peptide synthesis. J. Immunol. Methods. 102:1987;259-274.
17. Kawczak J.A., Mathisen P.M., Drazba J.A., Fuss B., Macklin W.B., Tuohy V.K. Digitized image analysis shows diffuse abnormalities of normal appearing white matter during acute experimental autoimmune encephalomyelitis. J. Neurosci. Res. 54:1998;364-372.
18. Tuohy V.K., Lu Z., Sobel R.A., Laursen R.A., Lees M.B. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142:1989;1523-1526.
19. Tuohy V.K., Lu Z., Sobel R.A., Laursen R.A., Lees M.B. A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J. Immunol. 141:1988;1126-1130.
20. Tuohy V.K., Thomas D.M. Sequence 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice. J. Neuroimmunol. 56:1995;161-170.
21. Greer J.M., Kuchroo V.K., Sobel R.A., Lees M.B. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J. Immunol. 149:1992;783-788.
22. Kono D.H., Urban J.L., Horvath S.J., Ando D.G., Saavedra R.A., Hood L. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice. J. Exp. Med. 168:1988;213-227.
23. Sakai K., Zamvil S.S., Mitchell D.J., Lim M., Rothbard J.B., Steinman L. Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein. J. Neuroimmunol. 19:1988;21-32.
24. Cross A.H., Hashim G.A., Raine C.S. Adoptive transfer of experimental allergic encephalomyelitis and localization of the encephalitogenic epitopc in the SWR mouse. J. Neuroimmunol. 31:1991;59-66.
25. Amor S., Groome N., Linington C., Morris M.M., Dornmair K., Gardinier M.V., Matthieu J.M., Baker D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153:1994;4349-4356.
26. +T cells compared. J. Immunol. 154:1995;4309-4321.
27. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
28. Novotny J., Bruccoleri R.E., Carlson W.D., Handschumacher M., Haber E. Antigenicity of myohemerythrin. Science. 238:1987;1584-1586.
29. Schwartz R.H. A cell culture model for T lymphocyte clonal anergy. Science. 248:1990;1349-1356.
30. DeSilva D.R., Urdahl K.B., Jenkins M.K. Clonal energy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147:1991;3261-3267.
31. Correale J., Gilmore W., Lopez J., Li S.Q., McMillan M., Weiner L.P. Defective post-thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosis. Nature Med. 2:1996;1354-1360.
32. van Parijs L.V., Perez V.L., Biuckians A., Maki R.G., London C.A., Abbas A.K. Role of interleukin 12 and costimulators in T cell anergy in vivo. J. Exp. Med. 186:1997;1119-1128.
33. Tanguay S., Killion J.J. Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. Lymph. Cyt. Res. 13:1994;259-263.
34. Forsthuber T., Yip H.C., Lehmann P.V. Induction of TH1 and TH2 immunity in neonatal mice. Science. 271:1996;1728-1730.
35. Vandenbark A.A., Hashim G., Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature. 341:1989;541-544.
36. Offner H., Hashim G.A., Vandenbark A.A. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science. 251:1991;430-432.
37. Zhang J., Vandevyver C., Stinissen P., Raus J. In vivo clonotypic regulation of human myelin basic protein-reactive T cells by T cell vaccination. J. Immunol. 155:1995;5868-5877.
38. Pelfrey C.M., Tranquill L.R., Boehme S.A., McFarland H.F., Lenardo M.J. Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J. Immunol. 154:1995;6191-6202.
39. Tanaka H., Ota K., Ikusaka M., Ejima M., Maruyama S. Expression of Fas-antigen on T cells in multiple sclerosis [in Japanese]. Rinsho Shinkeigaku - Clin. Neurol. 35:1995;299-301.
40. Gallimore A., Glithero A., Godkin A., Tissot A.C., Pluckthun A., Elliott T., Hengartner H., Zinkernagel R. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1998;1383-1393.
41. Kozono H., White J., Clements J., Marrack P., Kappler J. Production of soluble MHC class II proteins with covalently bound single peptides. Nature. 369:1994;151-154.
42. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94-96.
43. O'Herrin S.M., Lebowitz M.S., Bieler J.G., Al-Ramadi B., Utz U., Bothwell A., Schneck J. Analysis of the expression of peptide-major histocompatability complexes using high affinity soluble divalent T cell receptors. J. Exp. Med. 186:1997;1333-1345.
44. +T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc. Natl. Acad. Sci. USA. 95:1998;7568-7573.